Matches in SemOpenAlex for { <https://semopenalex.org/work/W1547362808> ?p ?o ?g. }
- W1547362808 endingPage "1175" @default.
- W1547362808 startingPage "1175" @default.
- W1547362808 abstract "Alterations in cerebrospinal fluid (CSF) have been found in Parkinson disease (PD) and in PD dementia (PDD), but the prognostic importance of such changes is not well known. In vivo biomarkers for disease processes in PD are important for future development of disease-modifying therapies.To assess the diagnostic and prognostic value of a panel of CSF biomarkers in patients with early PD and related disorders.Regional population-based, prospective cohort study of idiopathic parkinsonism that included patients diagnosed between January 1, 2004, and April 30, 2009, by a movement disorder team at a university hospital that represented the only neurology clinic in the region. Participants were 128 nondemented patients with new-onset parkinsonism (104 with PD, 11 with multiple system atrophy, and 13 with progressive supranuclear palsy) who were followed up for 5 to 9 years. At baseline, CSF from 30 healthy control participants was obtained for comparison.Cerebrospinal fluid concentrations of neurofilament light chain protein, Aβ1-42, total tau, phosphorylated tau, α-synuclein, and heart fatty acid-binding protein were quantified by 2 blinded measurements (at baseline and after 1 year). Follow-up included an extensive neuropsychological assessment. As PD outcome variables, mild cognitive impairment and incident PDD were diagnosed based on published criteria.Among the 128 study participants, the 104 patients with early PD had a different CSF pattern compared with the 13 patients with progressive supranuclear palsy (baseline area under the receiver operating characteristic curve, 0.87; P < .0001) and the 30 control participants (baseline area under the receiver operating characteristic curve, 0.69; P = .0021). A CSF biomarker pattern associated with the development of PDD was observed. In PD, high neurofilament light chain protein, low Aβ1-42, and high heart fatty acid-binding protein at baseline were related to future PDD as analyzed by Cox proportional hazards regression models. Combined, these early biomarkers predicted PDD with high accuracy (hazard ratio, 11.8; 95% CI, 3.3-42.1; P = .0001) after adjusting for possible confounders.The analyzed CSF biomarkers have potential usefulness as a diagnostic tool in patients with parkinsonism. In PD, high neurofilament light chain protein, low Aβ1-42, and high heart fatty acid-binding protein were related to future PDD, providing new insights into the etiology of PDD." @default.
- W1547362808 created "2016-06-24" @default.
- W1547362808 creator A5010172490 @default.
- W1547362808 creator A5027498563 @default.
- W1547362808 creator A5041986125 @default.
- W1547362808 creator A5054245222 @default.
- W1547362808 creator A5060565917 @default.
- W1547362808 creator A5066691500 @default.
- W1547362808 creator A5068394264 @default.
- W1547362808 creator A5079766290 @default.
- W1547362808 creator A5015925593 @default.
- W1547362808 date "2015-10-01" @default.
- W1547362808 modified "2023-09-29" @default.
- W1547362808 title "Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease" @default.
- W1547362808 cites W1598254921 @default.
- W1547362808 cites W1963880027 @default.
- W1547362808 cites W1966840925 @default.
- W1547362808 cites W1967431514 @default.
- W1547362808 cites W1969233797 @default.
- W1547362808 cites W1969895941 @default.
- W1547362808 cites W1971579987 @default.
- W1547362808 cites W1983700255 @default.
- W1547362808 cites W1985262420 @default.
- W1547362808 cites W1985703940 @default.
- W1547362808 cites W1992165389 @default.
- W1547362808 cites W2006696253 @default.
- W1547362808 cites W2007350172 @default.
- W1547362808 cites W2012122478 @default.
- W1547362808 cites W2019709557 @default.
- W1547362808 cites W2021453132 @default.
- W1547362808 cites W2028133242 @default.
- W1547362808 cites W2044966777 @default.
- W1547362808 cites W2053919734 @default.
- W1547362808 cites W2059431752 @default.
- W1547362808 cites W2075275965 @default.
- W1547362808 cites W2085851888 @default.
- W1547362808 cites W2093508373 @default.
- W1547362808 cites W2098992836 @default.
- W1547362808 cites W2107172544 @default.
- W1547362808 cites W2107544493 @default.
- W1547362808 cites W2111171093 @default.
- W1547362808 cites W2115026925 @default.
- W1547362808 cites W2131434127 @default.
- W1547362808 cites W2134113727 @default.
- W1547362808 cites W2134323711 @default.
- W1547362808 cites W2136557657 @default.
- W1547362808 cites W2137070022 @default.
- W1547362808 cites W2152575748 @default.
- W1547362808 cites W2156013560 @default.
- W1547362808 cites W2160719857 @default.
- W1547362808 cites W2166609052 @default.
- W1547362808 cites W2171325190 @default.
- W1547362808 cites W2112442563 @default.
- W1547362808 doi "https://doi.org/10.1001/jamaneurol.2015.1449" @default.
- W1547362808 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26258692" @default.
- W1547362808 hasPublicationYear "2015" @default.
- W1547362808 type Work @default.
- W1547362808 sameAs 1547362808 @default.
- W1547362808 citedByCount "140" @default.
- W1547362808 countsByYear W15473628082015 @default.
- W1547362808 countsByYear W15473628082016 @default.
- W1547362808 countsByYear W15473628082017 @default.
- W1547362808 countsByYear W15473628082018 @default.
- W1547362808 countsByYear W15473628082019 @default.
- W1547362808 countsByYear W15473628082020 @default.
- W1547362808 countsByYear W15473628082021 @default.
- W1547362808 countsByYear W15473628082022 @default.
- W1547362808 countsByYear W15473628082023 @default.
- W1547362808 crossrefType "journal-article" @default.
- W1547362808 hasAuthorship W1547362808A5010172490 @default.
- W1547362808 hasAuthorship W1547362808A5015925593 @default.
- W1547362808 hasAuthorship W1547362808A5027498563 @default.
- W1547362808 hasAuthorship W1547362808A5041986125 @default.
- W1547362808 hasAuthorship W1547362808A5054245222 @default.
- W1547362808 hasAuthorship W1547362808A5060565917 @default.
- W1547362808 hasAuthorship W1547362808A5066691500 @default.
- W1547362808 hasAuthorship W1547362808A5068394264 @default.
- W1547362808 hasAuthorship W1547362808A5079766290 @default.
- W1547362808 hasConcept C118552586 @default.
- W1547362808 hasConcept C126322002 @default.
- W1547362808 hasConcept C142724271 @default.
- W1547362808 hasConcept C16568411 @default.
- W1547362808 hasConcept C187212893 @default.
- W1547362808 hasConcept C188816634 @default.
- W1547362808 hasConcept C2776477761 @default.
- W1547362808 hasConcept C2776525014 @default.
- W1547362808 hasConcept C2779134260 @default.
- W1547362808 hasConcept C2779483572 @default.
- W1547362808 hasConcept C2779651940 @default.
- W1547362808 hasConcept C2779734285 @default.
- W1547362808 hasConcept C2781172350 @default.
- W1547362808 hasConcept C2908647359 @default.
- W1547362808 hasConcept C58471807 @default.
- W1547362808 hasConcept C71924100 @default.
- W1547362808 hasConcept C72563966 @default.
- W1547362808 hasConcept C99454951 @default.
- W1547362808 hasConceptScore W1547362808C118552586 @default.
- W1547362808 hasConceptScore W1547362808C126322002 @default.